# A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis

> **NCT01742663** · PHASE1 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 435 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Diclofenac Sodium Gel 3%
- **DRUG:** Solaraze® (diclofenac sodium) Gel 3%
- **DRUG:** Vehicle Topical Gel

## Key facts

- **NCT ID:** NCT01742663
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-10
- **Target enrollment:** 435 (ACTUAL)
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01742663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01742663, "A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01742663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*